Intestinal microbiota in Coeliac disease (CD) compared to non-coeliac patients using Deoxyribonucleic Acid (DNA) methods of analysis, followed by a double-blind placebo controlled study assessing the microbiological and quality of life improvements after supplementation with a specific probiotic supplement.

Southern Cross University0 个研究点目标入组 45 人开始时间: 2010年8月2日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1.Pregnant women
•2.Participants under the age of 18
•3.Individuals with cancer or who are HIV positive
•4.Patients who have been diagnosed with Coeliac disease in the past 12 months
•5.Patients who consume a gluten containing diet
•6.Individuals with gastrointestinal pathology such as cancer, Crohn’s disease or ulcerative colitis
•7.Individuals with short bowel syndrome
•8.Individuals who have had recent oral or bowel surgery
•9.Individuals currently being treated with chemotherapy or radiotherapy
•10.People who are using or have used non-steroidal or steroidal anti-inflammatory drugs, antibiotics, antipyretics or the oral contraceptive pill in the four weeks prior to the start of the trial
•11.Individuals with serum urea, electrolytes and creatinine greater than 2 times the upper limit of normal at baseline
•12.Individuals with liver function tests greater than 3 times the upper limit of normal at baseline
•13.Participants unwilling to comply with the study protocol
•14.Any other condition which, in the opinion of the investigators, could compromise the study
•15.Individuals with active alcohol and or illicit drug dependence.

发起方